Management challenges in low-grade serous ovarian cancer with a BRCA mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management challenges in low-grade serous ovarian cancer with a BRCA mutation

Published:2024-04 Issue:4 Volume:34 Page:631-636
ISSN:1048-891X
Container-title:International Journal of Gynecologic Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

Sanchez-Lorenzo Luisa^ORCID,Sancho Lidia,Iscar Teresa,Grisham Rachel^ORCID,Chiva Luis^ORCID

Publisher

BMJ

Reference26 articles.

1. A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

2. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

3. Treatment with niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer: a phase 3 randomized clinical trial;Li;JAMA Oncol,2023

4. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

5. Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary;Takeuchi;Gynecol Oncol,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3